University of Alabama-Birmingham (UAB)

Birmingham, Alabama 35294-2050

1 studies enrolling now · 5 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, COPD, Emphysema, Healthy, Neuroendocrine Tumour of the Lung, Neuroendocrine Tumours, Parkinson's Disease, Sickle Cell Disease, Small Intestinal NET

Studies at this site

• Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease — Recruiting now
• Open-Label Surufatinib in European Patients With NET — Stopped early
• Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change — Completed
• Validation of Dyskinesia Rating Scales — Completed
• A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. — Completed